New drug for MS is milestone for patients, research

Ocrevus (ocrelizumab), a new drug to treat multiple sclerosis (MS), ?has been approved by the?U.S. Food and Drug Administration (FDA). The National Multiple Sclerosis Society?says it's a "game changer" and Dr. Dean Wingerchuk, a?Mayo Clinic neurologist, says, "The approval of ocrelizumab is an important milestone ? both for people with MS and MS research." In [...]
Source: Mayo Clinic Research News - Category: Research Source Type: news